Barré Syndrome.Expert O pin Investistig Drug 2000 oct.9 (10) : 2307-18.
47- Hughes RA. Hadden Rd.Pathogenesis of Guillain –Barré syndrome .J. Neuroinmunol 1999; Dec. 100(1-2): 74-97.
48- Haupt WF. Recent Advence of Therapeutic Apheresis in Guillain-Barré Sindrome. Ther Apher 2000 Aug: 4 (4) 271-4.
49- Robbins. Patología estruct y funcional. Méjico, McGraw-Hill-Interamericana, 2001: 1322).
50- Kuwabara S. Guillain Barré síndrome: epidemiology, pathophysiology and management. Drugs. 2004:64 (6):597-610.